Cargando…
Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19
COVID-19 is the biggest pandemic the world has seen this century. Alongside the respiratory damage observed in patients with severe forms of the disease, gastrointestinal symptoms have been frequently reported. These symptoms (e.g., diarrhoea), sometimes precede the development of respiratory tract...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114883/ https://www.ncbi.nlm.nih.gov/pubmed/35601094 http://dx.doi.org/10.3389/fcimb.2022.798767 |
_version_ | 1784709877798535168 |
---|---|
author | Osman, Ikram Omar Garrec, Clémence de Souza, Gabriel Augusto Pires Zarubica, Ana Belhaouari, Djamal Brahim Baudoin, Jean-Pierre Lepidi, Hubert Mege, Jean-Louis Malissen, Bernard Scola, Bernard La Devaux, Christian Albert |
author_facet | Osman, Ikram Omar Garrec, Clémence de Souza, Gabriel Augusto Pires Zarubica, Ana Belhaouari, Djamal Brahim Baudoin, Jean-Pierre Lepidi, Hubert Mege, Jean-Louis Malissen, Bernard Scola, Bernard La Devaux, Christian Albert |
author_sort | Osman, Ikram Omar |
collection | PubMed |
description | COVID-19 is the biggest pandemic the world has seen this century. Alongside the respiratory damage observed in patients with severe forms of the disease, gastrointestinal symptoms have been frequently reported. These symptoms (e.g., diarrhoea), sometimes precede the development of respiratory tract illnesses, as if the digestive tract was a major target during early SARS-CoV-2 dissemination. We hypothesize that in patients carrying intestinal SARS-CoV-2, the virus may trigger epithelial barrier damage through the disruption of E-cadherin (E-cad) adherens junctions, thereby contributing to the overall gastrointestinal symptoms of COVID-19. Here, we use an intestinal Caco-2 cell line of human origin which expresses the viral receptor/co-receptor as well as the membrane anchored cell surface adhesion protein E-cad to investigate the expression of E-cad after exposure to SARS-CoV-2. We found that the expression of CDH1/E-cad mRNA was significantly lower in cells infected with SARS-CoV-2 at 24 hours post-infection, compared to virus-free Caco-2 cells. The viral receptor ACE2 mRNA expression was specifically down-regulated in SARS-CoV-2-infected Caco-2 cells, while it remained stable in HCoV-OC43-infected Caco-2 cells, a virus which uses HLA class I instead of ACE2 to enter cells. It is worth noting that SARS-CoV-2 induces lower transcription of TMPRSS2 (involved in viral entry) and higher expression of B(0)AT1 mRNA (that encodes a protein known to co-express with ACE2 on intestinal cells). At 48 hours post-exposure to the virus, we also detected a small but significant increase of soluble E-cad protein (sE-cad) in the culture supernatant of SARS-CoV-2-infected Caco-2 cells. The increase of sE-cad release was also found in the intestinal HT29 cell line when infected by SARS-CoV-2. Beside the dysregulation of E-cad, SARS-CoV-2 infection of Caco-2 cells also leads to the dysregulation of other cell adhesion proteins (occludin, JAMA-A, zonulin, connexin-43 and PECAM-1). Taken together, these results shed light on the fact that infection of Caco-2 cells with SARS-CoV-2 affects tight-, adherens-, and gap-junctions. Moreover, intestinal tissues damage was associated to the intranasal SARS-CoV-2 infection in human ACE2 transgenic mice. |
format | Online Article Text |
id | pubmed-9114883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91148832022-05-19 Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19 Osman, Ikram Omar Garrec, Clémence de Souza, Gabriel Augusto Pires Zarubica, Ana Belhaouari, Djamal Brahim Baudoin, Jean-Pierre Lepidi, Hubert Mege, Jean-Louis Malissen, Bernard Scola, Bernard La Devaux, Christian Albert Front Cell Infect Microbiol Cellular and Infection Microbiology COVID-19 is the biggest pandemic the world has seen this century. Alongside the respiratory damage observed in patients with severe forms of the disease, gastrointestinal symptoms have been frequently reported. These symptoms (e.g., diarrhoea), sometimes precede the development of respiratory tract illnesses, as if the digestive tract was a major target during early SARS-CoV-2 dissemination. We hypothesize that in patients carrying intestinal SARS-CoV-2, the virus may trigger epithelial barrier damage through the disruption of E-cadherin (E-cad) adherens junctions, thereby contributing to the overall gastrointestinal symptoms of COVID-19. Here, we use an intestinal Caco-2 cell line of human origin which expresses the viral receptor/co-receptor as well as the membrane anchored cell surface adhesion protein E-cad to investigate the expression of E-cad after exposure to SARS-CoV-2. We found that the expression of CDH1/E-cad mRNA was significantly lower in cells infected with SARS-CoV-2 at 24 hours post-infection, compared to virus-free Caco-2 cells. The viral receptor ACE2 mRNA expression was specifically down-regulated in SARS-CoV-2-infected Caco-2 cells, while it remained stable in HCoV-OC43-infected Caco-2 cells, a virus which uses HLA class I instead of ACE2 to enter cells. It is worth noting that SARS-CoV-2 induces lower transcription of TMPRSS2 (involved in viral entry) and higher expression of B(0)AT1 mRNA (that encodes a protein known to co-express with ACE2 on intestinal cells). At 48 hours post-exposure to the virus, we also detected a small but significant increase of soluble E-cad protein (sE-cad) in the culture supernatant of SARS-CoV-2-infected Caco-2 cells. The increase of sE-cad release was also found in the intestinal HT29 cell line when infected by SARS-CoV-2. Beside the dysregulation of E-cad, SARS-CoV-2 infection of Caco-2 cells also leads to the dysregulation of other cell adhesion proteins (occludin, JAMA-A, zonulin, connexin-43 and PECAM-1). Taken together, these results shed light on the fact that infection of Caco-2 cells with SARS-CoV-2 affects tight-, adherens-, and gap-junctions. Moreover, intestinal tissues damage was associated to the intranasal SARS-CoV-2 infection in human ACE2 transgenic mice. Frontiers Media S.A. 2022-05-04 /pmc/articles/PMC9114883/ /pubmed/35601094 http://dx.doi.org/10.3389/fcimb.2022.798767 Text en Copyright © 2022 Osman, Garrec, de Souza, Zarubica, Belhaouari, Baudoin, Lepidi, Mege, Malissen, Scola and Devaux https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Osman, Ikram Omar Garrec, Clémence de Souza, Gabriel Augusto Pires Zarubica, Ana Belhaouari, Djamal Brahim Baudoin, Jean-Pierre Lepidi, Hubert Mege, Jean-Louis Malissen, Bernard Scola, Bernard La Devaux, Christian Albert Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19 |
title | Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19 |
title_full | Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19 |
title_fullStr | Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19 |
title_full_unstemmed | Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19 |
title_short | Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19 |
title_sort | control of cdh1/e-cadherin gene expression and release of a soluble form of e-cadherin in sars-cov-2 infected caco-2 intestinal cells: physiopathological consequences for the intestinal forms of covid-19 |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114883/ https://www.ncbi.nlm.nih.gov/pubmed/35601094 http://dx.doi.org/10.3389/fcimb.2022.798767 |
work_keys_str_mv | AT osmanikramomar controlofcdh1ecadheringeneexpressionandreleaseofasolubleformofecadherininsarscov2infectedcaco2intestinalcellsphysiopathologicalconsequencesfortheintestinalformsofcovid19 AT garrecclemence controlofcdh1ecadheringeneexpressionandreleaseofasolubleformofecadherininsarscov2infectedcaco2intestinalcellsphysiopathologicalconsequencesfortheintestinalformsofcovid19 AT desouzagabrielaugustopires controlofcdh1ecadheringeneexpressionandreleaseofasolubleformofecadherininsarscov2infectedcaco2intestinalcellsphysiopathologicalconsequencesfortheintestinalformsofcovid19 AT zarubicaana controlofcdh1ecadheringeneexpressionandreleaseofasolubleformofecadherininsarscov2infectedcaco2intestinalcellsphysiopathologicalconsequencesfortheintestinalformsofcovid19 AT belhaouaridjamalbrahim controlofcdh1ecadheringeneexpressionandreleaseofasolubleformofecadherininsarscov2infectedcaco2intestinalcellsphysiopathologicalconsequencesfortheintestinalformsofcovid19 AT baudoinjeanpierre controlofcdh1ecadheringeneexpressionandreleaseofasolubleformofecadherininsarscov2infectedcaco2intestinalcellsphysiopathologicalconsequencesfortheintestinalformsofcovid19 AT lepidihubert controlofcdh1ecadheringeneexpressionandreleaseofasolubleformofecadherininsarscov2infectedcaco2intestinalcellsphysiopathologicalconsequencesfortheintestinalformsofcovid19 AT megejeanlouis controlofcdh1ecadheringeneexpressionandreleaseofasolubleformofecadherininsarscov2infectedcaco2intestinalcellsphysiopathologicalconsequencesfortheintestinalformsofcovid19 AT malissenbernard controlofcdh1ecadheringeneexpressionandreleaseofasolubleformofecadherininsarscov2infectedcaco2intestinalcellsphysiopathologicalconsequencesfortheintestinalformsofcovid19 AT scolabernardla controlofcdh1ecadheringeneexpressionandreleaseofasolubleformofecadherininsarscov2infectedcaco2intestinalcellsphysiopathologicalconsequencesfortheintestinalformsofcovid19 AT devauxchristianalbert controlofcdh1ecadheringeneexpressionandreleaseofasolubleformofecadherininsarscov2infectedcaco2intestinalcellsphysiopathologicalconsequencesfortheintestinalformsofcovid19 |